Ductal intraepithelial neoplasia (IDH, AIDH and DCIS)

[1] Ernster, V.L., Barclay, J., Kerlikowske, K., Wilkie, H., Ballard-Barbash, R., Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program (2000) Archives of Internal Medicine, 160 (7), pp. 953-958

[2] Page, D.L., Vander Zwaag, R., Rogers, L.W., Relation between component parts of fibrocystic disease complex and breast cancer (1978) Journal of the National Cancer Institute, 61 (4), pp. 1055-1063

[3] Page, D.L., Dupont, W.D., Rogers, L.W., Rados, M.S., Atypical hyperplastic lesions of the female breast. A long-term follow-up study (1985) Cancer, 55 (11), pp. 2698-2708. , DOI 10.1002/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0. CO

[4] 2-A

[5] Tavassoli, F.A., Norris, H.J., A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast (1990) Cancer, 65, p. 518

[6] Dupont, W.D., Page, D.L., Risk factors for breast cancer in women with proliferative breast disease (1985) New England Journal of Medicine, 312 (3), pp. 146-151

[7] Page, D.L., Dupont, W.D., Rogers, L.W., Landenberger, M., Intraductal carcinoma of the breast: Follow-up after biopsy only (1982) Cancer, 49 (4), pp. 751-758

[8] Rosai, K., Borderline epithelial lesions of the breast (1991) Am J Surg Pathol, 15, pp. 209-221

[9] Schnitt, S.J., Connolly, J.L., Tavassoli, F.A., Fechner, R.E., Kempson, R.L., Gelman, R., Page, D.L., Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria (1992) American Journal of Surgical Pathology, 16 (12), pp. 1133-1143. , DOI 10.1097/00000478-199212000-00001

[10] Palazzo, J.P., Hyslop, T., Hyperplastic ductal and lobular lesions and carcinomas in situ of the breast: Reproducibility of current diagnostic criteria among community- and academic-based pathologists (1998) Breast Journal, 4 (4), pp. 230-237

[1] Ernster, V.L., Barclay, J., Kerlikowske, K., Wilkie, H., Ballard-Barbash, R., Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program (2000) Archives of Internal Medicine, 160 (7), pp. 953-958

[2] Page, D.L., Vander Zwaag, R., Rogers, L.W., Relation between component parts of fibrocystic disease complex and breast cancer (1978) Journal of the National Cancer Institute, 61 (4), pp. 1055-1063

[3] Page, D.L., Dupont, W.D., Rogers, L.W., Rados, M.S., Atypical hyperplastic lesions of the female breast. A long-term follow-up study (1985) Cancer, 55 (11), pp. 2698-2708. , DOI 10.1002/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0. CO

[4] 2-A

[5] Tavassoli, F.A., Norris, H.J., A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast (1990) Cancer, 65, p. 518

[6] Dupont, W.D., Page, D.L., Risk factors for breast cancer in women with proliferative breast disease (1985) New England Journal of Medicine, 312 (3), pp. 146-151

[7] Page, D.L., Dupont, W.D., Rogers, L.W., Landenberger, M., Intraductal carcinoma of the breast: Follow-up after biopsy only (1982) Cancer, 49 (4), pp. 751-758

[8] Rosai, K., Borderline epithelial lesions of the breast (1991) Am J Surg Pathol, 15, pp. 209-221

[9] Schnitt, S.J., Connolly, J.L., Tavassoli, F.A., Fechner, R.E., Kempson, R.L., Gelman, R., Page, D.L., Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria (1992) American Journal of Surgical Pathology, 16 (12), pp. 1133-1143. , DOI 10.1097/00000478-199212000-00001

[10] Palazzo, J.P., Hyslop, T., Hyperplastic ductal and lobular lesions and carcinomas in situ of the breast: Reproducibility of current diagnostic criteria among community- and academic-based pathologists (1998) Breast Journal, 4 (4), pp. 230-237